YS Biopharma Company Ltd (YS)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2023 | Sep 2023 | |
|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 176.27M | 96.82M | |
| Operating Income | -70.05M | -113.21M | |
| Pre Tax Income | -70.13M | -105.22M | |
| Net Income | -69.54M | -104.98M | |
| Preferred Dividends | 0 | 0 | |
| Basic Earnings Per Share (EPS) | 0 | 0 | |
| EBIT | -68.79M | -100.43M | |
| EBITDA | -70.05M | -93.27M |
| Year End March 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 257.02M | 502.95M | 687.2M |
| Operating Income | -125.85M | -118.96M | -139.38M |
| Pre Tax Income | -174.37M | -101.07M | -144.35M |
| Net Income | -208.44M | -236.67M | -283.47M |
| Preferred Dividends | -16.61M | -130.66M | 0 |
| Basic Earnings Per Share (EPS) | -0.843 | -0.957 | -3.046 |
| EBIT | -144.68M | -98.35M | -113.51M |
| EBITDA | -97.94M | -87.81M | -102.69M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
